Update on Chinese Regulated Bioanalysis

7 Feb 2016

Written by Dafang Zhong 1, Kelly Dong 2, Minji Wei 3, Jintong Li 4, Daniel Tang 5,*

This is article is available as part of our Focus on China, to view all other articles available as part of this feature click here. 1 Shanghai Institute of Materia Medica (SIMM), Chinese Academy of Sciences 2 GlaxoSmithKline R&D Shanghai 3 Institute of Clinical Pharmacology, Peking University 4 Beijing eStart Medical Technology 5 United-Power PharmaTech (*Corresponding author, [email protected]) Fast growing pharmaceutical R&D in China China has become the second largest economy this decade with an average GDP growth of > 8% in the past 30 years. Meanwhile the Chinese pharmaceutical market has grown to the second largest in the world...